Research so far include:
Animal studies have shown that N-nitroso compounds are powerful carcinogens to be able to pass placenta to the developing fetus. They are considered to be risk factors for certain adult cancers. It is hypothesised that these compounds synthesised from relevant food stuffs (e.g., excessive hot dog and cured meat consumptions) ingested by mothers during pregnancy might act as carcinogens passing through the placenta and that a high intake of fruit and vegetables or vitamin C supplements may play protective roles. This hypothesis has been tested in a number of studies focused on childhood brain tumours. The studies reported an association between these compounds during pregnancy and subsequent childhood brain tumour in offspring. It is also implied in childhood leukaemia.
Flavonoids, referred as bioflavonoid in media, are commonly known for their antioxidant activity. Good dietary sources of flavonoids include all citrus fruits, berries, onions, parsley, green tea, red wine and dark chocolate. Some of these flavonoids, known as DNA topoisomerase (DNAt2) inhibitors, have been shown to cause site-specific DNA cleavage in the MLL gene breakpoint cluster region on chromosome 11q23. It has been, therefore hypothesised that the infant leukaemias (of which 80% have the MLL abnormality) may occur as a result of maternal exposure to flavonoids in diet during pregnancy and medications that inhibit DNAt2. Contradictory associations have been reported in various studies.
DES is a synthetic non-steroidal oestrogen drug that was first synthesized in 1938. In 1971, it was found to be a teratogen (refers to disfiguring birth defects or malformation) when given to pregnant women. During the 1960s, DES was used as a growth hormone in the beef and poultry industry. It was later found to cause cancer and was phased out in the late 1970s. Studies demonstrated that cancer could be induced by DES passing through the placenta. Another study found that DES could be trans-generational meaning that the third generation may be effected by the DES used by the maternal grandmother.
Animal studies provided evidence that some genotoxic and carcinogenic compounds can pass placenta to the developing fetus. Because of this it is hypothesised that exposure to these agents during pregnancy is a risk factor for childhood cancers. However, no consistent associations were reported between maternal exposures to these agents and childhood cancers.
Studies did not find any consistent association between maternal tobacco smoking during pregnancy and any type of childhood cancer. Possible association has been reported between paternal smoking and ALL. Positive association has been reported between maternal alcohol consumption during pregnancy and AML.
It has been reported that there is an increased risk for AML with anemia detected during pregnancy. It has been also reported that anemia should be examined along with other factors.
ALL has been attributed to an infectious exposure of the fetus during the pregnancy but no evidence has been found to support this theory.